Male Infertility Market Analysis, Size, Share & Growth Forecast 2026–2034

Varicocoele Repair Meta-Analysis 9 to 11 Million Total Motile Sperm Count Improvement and Spontaneous Pregnancy Rate Improvement Versus No Treatment Has Established the Surgical Ligation as the Correctable Male Infertility Intervention Treating the Most Common Surgically Reversible Cause.MicroTESE performed by experienced microsurgeons achieves sperm retrieval in 40-60% of non-obstructive azoospermia cases where conventional TESE achieves only 15-20%, through the selective identification of focal spermatogenesis at the tubule wall level under 15-25x magnification that conventional TESE cannot perform. The sperm retrieval advantage of microTESE translates directly into the proportion of couples who can proceed to ICSI, and fertility programmes at major academic centres including Cornell Weill, Cleveland Clinic, and UCSF have demonstrated that microTESE expertise is a significant determinant of treatment success in the azoospermic male partner. AUA and EAU guidelines recommend microTESE as the preferred surgical sperm retrieval technique for NOA and recognise that operator experience at high-volume fertility centres substantially influences the 40-60% retrieval rate, creating referral patterns to specialised centres that are analogous to complex cardiac or cancer surgery volume-outcome relationships.

Micro-TESE 40 to 60 Percent Non-Obstructive Azoospermia Sperm Retrieval Success From Microscopically Identified Focal Spermatogenesis Has Established the Microscope-Guided Technique as Superior to Conventional TESE That Cannot Identify the Focal Foci Without Magnification.The FUNGO and FRESH trials of FSH supplementation in idiopathic oligozoospermic men demonstrate significant improvement in sperm concentration and pregnancy rates overall but with substantial inter-individual variability that clinical predictors including FSHR polymorphism Asn680Ser are beginning to explain. Men homozygous for the Asn allele at FSHR position 680 demonstrate superior FSH response in meta-analyses of FSH treatment trials, and a small proportion of idiopathic oligospermia cases is attributable to partial FSH receptor insensitivity that high-dose FSH can overcome through receptor saturation at supraphysiological concentrations. The practical implementation of pharmacogenomic FSH prescribing in male infertility requires FSHR genotyping through commercially available panels and algorithm-based dose selection that fertility specialists at genomics-integrated clinics are incorporating into personalised male infertility protocols.

Y Chromosome AZFc Deletion 50 to 70 Percent Sperm Retrieval Prognosis Versus AZFa and AZFb Complete Azoospermia Prediction Has Established the Y Microdeletion Pattern as the Genetic Counselling Guide for the NOA Patient Considering the TESE Sperm Retrieval Attempt.The Cochrane meta-analysis of oral antioxidant supplementation in male infertility identified 61 randomised trials with predominantly low-quality evidence showing higher live birth rate relative risk of 1.73 for antioxidants versus placebo but with high heterogeneity across trials that limits confidence in the pooled estimate. The MOXI and EMPReSS UK Clinical Research Network trials with high-quality methodology and live birth rate primary endpoints failed to demonstrate significant improvement for CoQ10 or combined antioxidant supplementation in idiopathic male infertility, and the negative results from adequately powered trials have moderated the prior enthusiasm for antioxidant prescribing in male fertility clinics. Despite the negative high-quality trial evidence, antioxidant supplementation has maintained substantial commercial activity through consumer direct-to-consumer marketing of fertility supplements from Male Fertility, Fertilaid, and clinical fertility supplement brands that generate over USD 200 million annually in a market that operates largely independently of the prescription pharmaceutical channel.

For related market intelligence, see the Female Infertility Market.